Furthermore, in studies reported by our laboratory and others as well, it has already been shown that the proinflammatory cytokine TNF-β promotes tumor progression and thus activates CRC cells malignancy (HCT116 cells and HCT116 5-FU resistant cells) with the same efficacy as TNF-α (23, 62, 63). Here, TNF is linked to neoplasm.